Equities

Invesque Inc

Invesque Inc

Actions
  • Price (USD)0.20
  • Today's Change0.00 / 0.00%
  • Shares traded1.61k
  • 1 Year change-76.47%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024 19:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Invesque Inc. is a healthcare real estate company. The Company is focused on investing in a portfolio of North American properties across the health care spectrum. The Company's portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties, which are operated under long-term leases and joint venture arrangements with operating partners. Its portfolio also includes investments in owner-occupied seniors housing properties in which the Company owns the real estate and provides management services through its subsidiary management company, Commonwealth Senior Living. The Company owns or has a majority interest in a portfolio of approximately 68 properties in the United States, comprised of 57 assisted living and memory care facilities, nine skilled nursing facilities and two medical office buildings.

  • Revenue in USD (TTM)192.83m
  • Net income in USD-90.11m
  • Incorporated2016
  • Employees18.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.